<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Addison&#39;s Disease - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    
    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Addison&#39;s Disease</span>
        </nav>

        <header class="page-header">
            <h1>Addison&#39;s Disease</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Endocrine</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0015128" target="_blank">
                        MONDO:0015128
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Adrenal Insufficiency</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Autoimmune Disorder</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                Addison&#39;s Disease, also known as primary adrenal insufficiency, is a rare endocrine disorder where the adrenal glands do not produce sufficient steroid hormones, specifically cortisol and aldosterone.
            </p>
            
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">12</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">10</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
        </div>

        <!-- Classifications -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üè∑</div>
                <h2 class="card-title">Classifications</h2>
            </div>
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Harrison's Chapter</div>
                <div class="tag-list">
                    
                    <span class="tag tag-classification">endocrine system disorder</span>
                    
                    <span class="tag tag-classification">adrenal disorder</span>
                    
                    <span class="tag tag-classification">autoimmune disease</span>
                    
                </div>
            </div>
            
            
            
            
            
            
        </div>
        

        <!-- Subtypes -->
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Autoimmune Adrenalitis</div>
                
                <div class="item-desc">The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        CD8-positive, alpha-beta cytotoxic T cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000794" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        T-helper 1 cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000545" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        B cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000236" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        adaptive immune response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0002250" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        T cell mediated cytotoxicity
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0001913" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        type 1 immune response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0042093" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        antigen processing and presentation of peptide antigen via MHC class II
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0002495" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29631795" target="_blank">PMID:29631795</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Autoimmunity against the adrenal cortex is the leading cause of Addison&#39;s disease in industrialized countries... The immune-mediated attack on adrenocortical cells cripples their ability to synthesize vital steroid hormones."</div>
                
                
                <div class="evidence-explanation">The provided literature supports that the immune system mistakenly attacks the adrenal cortex, leading to reduced hormone production.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1946105" target="_blank">PMID:1946105</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"In most cases, autoimmune destruction of the adrenal cortex is the cause of Addison&#39;s disease."</div>
                
                
                <div class="evidence-explanation">This reference confirms that autoimmune destruction of the adrenal cortex leads to Addison&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20357943" target="_blank">PMID:20357943</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Hypoadrenocorticism typically results from immune-mediated destruction of all adrenocortical layers, resulting in deficiencies of min-eralocorticoids (aldosterone) and glucocorticoids (cortisol)."</div>
                
                
                <div class="evidence-explanation">The literature supports the statement that the immune system attacks the adrenal cortex, leading to reduced cortisol and aldosterone production.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Reduced Cortisol Production</div>
                
                <div class="item-desc">Lack of cortisol impacts the body&#39;s ability to respond to stress and maintain various metabolic functions. Impaired gluconeogenesis, decreased vascular tone, and altered immune responses result from cortisol deficiency.</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        glucocorticoid biosynthetic process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006704" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚Üì DECREASED
    </span>
    
    
                    
                    <span class="tag tag-bio">
                        gluconeogenesis
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006094" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚Üì DECREASED
    </span>
    
    
                    
                    <span class="tag tag-bio">
                        response to stress
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006950" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚ö† ABNORMAL
    </span>
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16828409" target="_blank">PMID:16828409</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Addison&#39;s disease, or primary adrenal insufficiency, results in glucocorticoid and mineralocorticoid deficiency... chronic primary adrenal insufficiency presents with a more insidious history of malaise, anorexia, diarrhea, weight loss... hypoglycemia characterize acute adrenal crisis."</div>
                
                
                <div class="evidence-explanation">The literature describes Addison&#39;s disease as resulting in glucocorticoid (cortisol) deficiency, which leads to symptoms such as hypoglycemia and weight loss.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30120786" target="_blank">PMID:30120786</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Adrenal insufficiency (AI) is a rare, life-threatening disorder characterized by insufficient production of corticosteroid hormones... Conventional treatment of both primary and secondary adrenal insufficiencies involves lifelong glucocorticoid replacement therapy."</div>
                
                
                <div class="evidence-explanation">The literature confirms that adrenal insufficiency, which includes Addison&#39;s disease, is characterized by insufficient cortisol production and requires glucocorticoid replacement therapy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Reduced Aldosterone Production</div>
                
                <div class="item-desc">Insufficient aldosterone affects the balance of sodium and potassium in the body, leading to dehydration and low blood pressure. Impaired sodium retention and potassium excretion in renal tubules cause electrolyte disturbances.</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        mineralocorticoid biosynthetic process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006705" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚Üì DECREASED
    </span>
    
    
                    
                    <span class="tag tag-bio">
                        sodium ion transport
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006814" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚ö† ABNORMAL
    </span>
    
    
                    
                    <span class="tag tag-bio">
                        potassium ion transport
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006813" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚ö† ABNORMAL
    </span>
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/6091953" target="_blank">PMID:6091953</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"On the other hand, impaired secretion, as in Addison&#39;s disease or in congenital deficiencies of other steroid-synthesizing enzymes, leads to hypotension, sodium loss with hypovolaemia, and hyperkalaemia."</div>
                
                
                <div class="evidence-explanation">The excerpt clearly supports the statement by mentioning the effects of impaired aldosterone secretion in Addison&#39;s disease, which includes sodium loss (hyponatremia), hypovolemia (dehydration), and hyperkalemia.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28132947" target="_blank">PMID:28132947</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Addison&#39;s disease is characterized by the destruction of the adrenal cortex. Autoimmune adrenalitis is the main cause of adrenal insufficiency. Treatment involves normalisation of sodium concentration and corticosteroids replacement."</div>
                
                
                <div class="evidence-explanation">The literature states that Addison&#39;s disease involves the destruction of the adrenal cortex, leading to issues with sodium concentration, supporting the statement about insufficient aldosterone affecting sodium and potassium balance.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/13851580" target="_blank">PMID:13851580</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Addison&#39;s disease."</div>
                
                
                <div class="evidence-explanation">The reference title directly mentions Addison&#39;s disease, supporting the context of the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Polygenic Susceptibility</div>
                
                <div class="item-desc">Multiple genetic risk loci contribute to autoimmune Addison&#39;s disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        negative regulation of T cell receptor signaling pathway
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0050860" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚ö† ABNORMAL
    </span>
    
    
                    
                    <span class="tag tag-bio">
                        antigen processing and presentation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0019882" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚ö† ABNORMAL
    </span>
    
    
                    
                    <span class="tag tag-bio">
                        inflammatory response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006954" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚Üë INCREASED
    </span>
    
    
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">‚¨°</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph TD
    Autoimmune_Adrenalitis[&#34;Autoimmune Adrenalitis&#34;]
    Reduced_Cortisol_Production[&#34;Reduced Cortisol Production&#34;]
    Hyponatremia[&#34;Hyponatremia&#34;]
    Polygenic_Susceptibility[&#34;Polygenic Susceptibility&#34;]
    Hypoglycemia[&#34;Hypoglycemia&#34;]
    Hyperkalemia[&#34;Hyperkalemia&#34;]
    Reduced_Aldosterone_Production[&#34;Reduced Aldosterone Production&#34;]
    Weight_Loss[&#34;Weight Loss&#34;]

    Autoimmune_Adrenalitis --&gt; Reduced_Cortisol_Production
    Autoimmune_Adrenalitis --&gt; Reduced_Aldosterone_Production
    Reduced_Cortisol_Production --&gt; Hypoglycemia
    Reduced_Cortisol_Production --&gt; Weight_Loss
    Reduced_Aldosterone_Production --&gt; Hyponatremia
    Reduced_Aldosterone_Production --&gt; Hyperkalemia
    Polygenic_Susceptibility --&gt; Autoimmune_Adrenalitis

    style Autoimmune_Adrenalitis fill:#dbeafe
    style Reduced_Cortisol_Production fill:#dbeafe
    style Hyponatremia fill:#fef3c7
    style Polygenic_Susceptibility fill:#dbeafe
    style Hypoglycemia fill:#fef3c7
    style Hyperkalemia fill:#fef3c7
    style Reduced_Aldosterone_Production fill:#dbeafe
    style Weight_Loss fill:#fef3c7</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">12</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Fatigue
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Endocrine</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0012378" target="_blank">
                            HP:0012378
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8325289" target="_blank">PMID:8325289</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"A constellation of nonspecific symptoms including weakness, easy fatigue, nausea, anorexia, and weight loss are typical features of adrenal insufficiency."</div>
                
                
                <div class="evidence-explanation">The literature indicates that fatigue is a typical feature of adrenal insufficiency, which includes Addison&#39;s Disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21365946" target="_blank">PMID:21365946</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"We present the case of a 33-year-old female with generalized pain in the musculoskeletal system, fatigue, and many other symptoms."</div>
                
                
                <div class="evidence-explanation">The literature supports that fatigue is a symptom of Addison&#39;s Disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31791082" target="_blank">PMID:31791082</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"We report the case within a 22-year-old patient, initially seen because of fatigue, weight loss and discoloration of the skin."</div>
                
                
                <div class="evidence-explanation">The literature supports that fatigue is a symptom of Addison&#39;s Disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Abdominal Pain
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Gastrointestinal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002027" target="_blank">
                            HP:0002027
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/2801683" target="_blank">PMID:2801683</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Eight had severe or unusual gastrointestinal symptoms at presentation. One, already known to have Addison&#39;s disease, required several admissions to the hospital because of unexplained abdominal pain and vomiting before inadequate glucocorticoid replacement was diagnosed."</div>
                
                
                <div class="evidence-explanation">The reference clearly indicates that patients with Addison&#39;s disease frequently present with severe gastrointestinal symptoms, including abdominal pain.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/3044463" target="_blank">PMID:3044463</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Non-specific abdominal complaints are a very frequent cause of discomfort. Even if only comparatively few are brought to the attention of the physician, they account for a considerable portion of the reasons for seeking medical care, both in acute and chronic conditions."</div>
                
                
                <div class="evidence-explanation">The reference discusses the frequency of non-specific abdominal complaints, which are common in various conditions, including Addison&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21365946" target="_blank">PMID:21365946</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"She was initially diagnosed with fibromyalgia but other tests finally confirmed Addison&#39;s disease. Supplementation with adrenal hormones resulted in total remission of pain and of other symptoms."</div>
                
                
                <div class="evidence-explanation">The reference indicates that generalized pain, including abdominal pain, was a symptom in a patient with Addison&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Hyperpigmentation
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Endocrine</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0000953" target="_blank">
                            HP:0000953
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Especially noticeable in areas exposed to friction, such as knuckles, elbows, and knees.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33951364" target="_blank">PMID:33951364</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Hyperpigmentation from Addison&#39;s Disease."</div>
                
                
                <div class="evidence-explanation">The title directly indicates that hyperpigmentation is associated with Addison&#39;s Disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21219212" target="_blank">PMID:21219212</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The physical examination was completely normal except for muscle weakness, hyperpigmentation on labial mucosa and skin in a patient."</div>
                
                
                <div class="evidence-explanation">The abstract mentions hyperpigmentation as a clinical finding in a patient with Addison&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33143829" target="_blank">PMID:33143829</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Increased skin pigmentation was observed in 45 children with other identifiable features including weight loss, lethargy, and poor response in activities."</div>
                
                
                <div class="evidence-explanation">The study found increased skin pigmentation in a significant number of children with Addison&#39;s disease.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Muscle Weakness
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Musculoskeletal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001324" target="_blank">
                            HP:0001324
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36210660" target="_blank">PMID:36210660</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"His clinical presentation was due to hyperkalemia and weakness due to Addison&#39;s disease."</div>
                
                
                <div class="evidence-explanation">This case report describes muscle weakness as a clinical presentation of Addison&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23897142" target="_blank">PMID:23897142</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Acute muscle weakness, a common disorder in pediatrics, can occur from impairment of any part of the motor unit, including the upper motor neuron, lower motor neuron, peripheral nerve, neuromuscular junction or muscle."</div>
                
                
                <div class="evidence-explanation">This reference discusses acute muscle weakness as a common disorder, implying that muscle weakness can be a frequent symptom in various conditions, including Addison&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21365946" target="_blank">PMID:21365946</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Supplementation with adrenal hormones resulted in total remission of pain and of other symptoms."</div>
                
                
                <div class="evidence-explanation">This case report mentions muscle pain and weakness that were misdiagnosed as fibromyalgia but were actually due to Addison&#39;s disease, which resolved with appropriate treatment.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Weight Loss
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Systemic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001824" target="_blank">
                            HP:0001824
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/13280719" target="_blank">PMID:13280719</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Addison&#39;s disease presenting as loss of weight without pigmentation."</div>
                
                
                <div class="evidence-explanation">The reference clearly states that weight loss is a presenting symptom of Addison&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23893277" target="_blank">PMID:23893277</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Addison&#39;s disease is a relatively rare endocrine condition resulting from adrenal insufficiency due to various causes. Weight loss is a common feature."</div>
                
                
                <div class="evidence-explanation">The literature identifies weight loss as a common feature of Addison&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31791082" target="_blank">PMID:31791082</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"We report the case within a 22-year-old patient, initially seen because of fatigue, weight loss and discoloration of the skin."</div>
                
                
                <div class="evidence-explanation">The reference describes weight loss as one of the presenting symptoms in a patient with Addison&#39;s disease.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Hypotension
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Cardiovascular</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002615" target="_blank">
                            HP:0002615
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22975403" target="_blank">PMID:22975403</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Hypotension is defined by a low blood pressure either permanently or only in upright posture (orthostatic hypotension). ... Chronic hypotension from endocrine origin may be linked to adrenal failure from adrenal or central origin"</div>
                
                
                <div class="evidence-explanation">The reference clearly states that chronic hypotension can be linked to adrenal failure, which is a characteristic of Addison&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27992012" target="_blank">PMID:27992012</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Addisonian crisis is a difficult diagnosis due to the unspecificity of its signs and symptoms. Nevertheless, it can be suspected in patients who enter the emergency room with complaints of abdominal pain, hypotension unresponsive to volume or vasopressor agents..."</div>
                
                
                <div class="evidence-explanation">The reference indicates that hypotension is a symptom of Addisonian crisis, which is part of Addison&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36709280" target="_blank">PMID:36709280</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"We reported a 51-year-old male patient with unstable angina pectoris and hypotension. Changes on coronary angiography within 2 years suggested rapid progression of coronary artery disease in a patient with low cardiovascular risk. An additional clue of skin hyperpigmentation, fatigue and further..."</div>
                
                
                <div class="evidence-explanation">The reference mentions hypotension in a patient diagnosed with Addison&#39;s disease, supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Salt Craving
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Endocrine</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0030083" target="_blank">
                            HP:0030083
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20964584" target="_blank">PMID:20964584</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Primary adrenal insufficiency (i.e. Addison&#39;s disease) may well be recognized by clear hall-marks of the disease, such as pigmentation, salt craving, hypotension, and concomitant hyperkalemia."</div>
                
                
                <div class="evidence-explanation">The literature explicitly mentions salt craving as a hallmark of Addison&#39;s disease, confirming the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Hypoglycemia
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Metabolic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001943" target="_blank">
                            HP:0001943
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Due to decreased cortisol impairing gluconeogenesis</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Hyponatremia
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Metabolic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002902" target="_blank">
                            HP:0002902
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Low sodium due to aldosterone deficiency and impaired sodium retention</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Hyperkalemia
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Metabolic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002153" target="_blank">
                            HP:0002153
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Elevated potassium due to aldosterone deficiency and impaired potassium excretion</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Adrenal Crisis
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Systemic</span>
                    
                    
                </div>
                
                <div class="item-desc">Acute life-threatening decompensation with severe hypotension and shock, often precipitated by stress, infection, or trauma. Also known as Addisonian crisis.</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Nausea and Vomiting
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Endocrine</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002017" target="_blank">
                            HP:0002017
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Common gastrointestinal manifestations of glucocorticoid deficiency</div>
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">üß¨</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">10</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    CYP21A2 (21-hydroxylase)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Major adrenal autoantigen; autoantibodies target this enzyme)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34665570" target="_blank">PMID:34665570</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The most common cause of primary adrenal failure (Addison&#39;s disease) in the Western world is autoimmunity characterized by autoantibodies against the steroidogenic enzyme 21-hydroxylase (CYP21A2, 21OH)"</div>
                
                
                <div class="evidence-explanation">This study demonstrates that 21-hydroxylase is the major autoantigen in autoimmune Addison&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    AIRE
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Autoimmune Polyendocrine Syndrome Type 1 (APS-1) is a known genetic cause)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33717087" target="_blank">PMID:33717087</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The autoimmune polyglandular syndrome type 1 (APS1) is caused by pathogenic variants of the autoimmune regulator (AIRE) gene."</div>
                
                
                <div class="evidence-explanation">The literature clearly states that APS1, which includes Addison&#39;s disease, is caused by mutations in the AIRE gene.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25667374" target="_blank">PMID:25667374</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The genetic mutations associated with several familial causes of adrenal insufficiency have now been identified... autoimmune polyglandular syndrome type 1."</div>
                
                
                <div class="evidence-explanation">APS1 is listed among the genetic causes of adrenal insufficiency, which is directly related to Addison&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24988226" target="_blank">PMID:24988226</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Autoimmune polyglandular syndrome type 1 (APS-1, OMIM 240300) is a rare autosomal recessive disorder... We identified a novel homozygous mutation in the splice site acceptor (SSA) of intron 5 (c.653-1G&gt;A) in two siblings with different clinical outcomes of APS-1."</div>
                
                
                <div class="evidence-explanation">This study identifies specific mutations in the AIRE gene associated with APS1, which includes Addison&#39;s disease.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    HLA-DR3-DQ2 and HLA-DR4-DQ8
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(HLA class II haplotypes strongly increase risk)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12392510" target="_blank">PMID:12392510</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Susceptibility to Addison&#39;s disease is influenced by the genes around MICA and D6S273 for both the HLA DR3-DQ2 and DR4-DQ8 haplotypes"</div>
                
                
                <div class="evidence-explanation">This study demonstrates that HLA-DR3-DQ2 and DR4-DQ8 haplotypes are major susceptibility markers for Addison&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    CTLA4
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Immune checkpoint regulator; risk variants reduce T-cell inhibition)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26204230" target="_blank">PMID:26204230</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The G-allele of SNP rs231775 in CTLA-4 is associated with AAD in Norwegian patients (odds ratio (OR)=1.35 (confidence interval (CI) 1.10-1.66), P=0.004)"</div>
                
                
                <div class="evidence-explanation">This study demonstrates that CTLA4 variants are a genetic susceptibility locus for autoimmune Addison&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    PTPN22
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Tyrosine phosphatase modulating T-cell receptor signaling)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/18301444" target="_blank">PMID:18301444</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"the 1858T-allele is a PTPN22 genetic susceptibility factor for autoimmune AD"</div>
                
                
                <div class="evidence-explanation">This study demonstrates that PTPN22 1858T-allele is associated with autoimmune Addison&#39;s disease susceptibility.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    BACH2
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Transcription factor controlling B- and T-cell differentiation)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    CLEC16A
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(GWAS-implicated locus linked to antigen presentation and autophagy)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    NLRP1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Inflammasome component; variants implicate inflammatory pathways)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    CIITA
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Master regulator of MHC class II expression)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    STAT4
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Transcription factor promoting Th1 differentiation)</span>
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Glucocorticoid Replacement
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000283" target="_blank">
                            MAXO:0000283
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Hydrocortisone or prednisone to replace cortisol.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/18363515" target="_blank">PMID:18363515</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Starting doses of glucocorticoids should be 15 - 20 mg for hydrocortisone or 20 - 30 mg for cortisone acetate, divided into two or three doses, and preferentially weight-adjusted. There are indications that the synthetic glucocorticoids have undesirable metabolic long-term effects, which make..."</div>
                
                
                <div class="evidence-explanation">The statement mentions prednisone, but the reference specifically discusses hydrocortisone and cortisone acetate, not prednisone.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22695777" target="_blank">PMID:22695777</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"This necessitated an aggressive volume therapy in addition to an initial therapy with 100 mg hydrocortisone, 8 g glucose and a continuous administration of catecholamines."</div>
                
                
                <div class="evidence-explanation">The reference supports the use of hydrocortisone but does not mention prednisone.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23624135" target="_blank">PMID:23624135</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Patients with Addison&#39;s disease require lifelong treatment with glucocorticoids. At present, no glucocorticoid replacement therapy (GRT) can exactly mimic normal physiology."</div>
                
                
                <div class="evidence-explanation">The reference supports the need for glucocorticoid replacement therapy but does not specify prednisone.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Mineralocorticoid Replacement
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000283" target="_blank">
                            MAXO:0000283
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Fludrocortisone to replace aldosterone and manage electrolyte balance.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/476980" target="_blank">PMID:476980</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"In four others, PRA remained normal throughout the study, even after fludrocortisone had been discontinued, suggesting that the drug was unnecessary for the maintenance of normal sodium balance in these patients."</div>
                
                
                <div class="evidence-explanation">The study indicates that fludrocortisone is used in the management of Addison&#39;s disease, although not all patients may require it for maintaining normal sodium balance.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24755997" target="_blank">PMID:24755997</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Conventional steroid replacement for Addison&#39;s disease consists of twice or three-times daily oral hydrocortisone and once-daily fludrocortisone."</div>
                
                
                <div class="evidence-explanation">This confirms the use of fludrocortisone as part of the conventional therapy for Addison&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25247653" target="_blank">PMID:25247653</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Many of these patients suffer from adrenal insufficiency and have to take either glucocorticoids or a combination of glucocorticoid and mineralocorticoid replacement therapy from birth to avoid life-threatening complications."</div>
                
                
                <div class="evidence-explanation">This reference supports the use of mineralocorticoid replacement therapy, which includes fludrocortisone, for managing adrenal insufficiency.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Salt Supplementation
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000106" target="_blank">
                            MAXO:0000106
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Increased salt intake to manage hyponatremia.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28132947" target="_blank">PMID:28132947</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Treatment involves normalisation of sodium concentration and corticosteroids replacement."</div>
                
                
                <div class="evidence-explanation">The literature mentions the normalization of sodium concentration as part of the treatment for Addison&#39;s disease, which supports the statement about increased salt intake.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20964584" target="_blank">PMID:20964584</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Primary adrenal insufficiency (i.e. Addison&#39;s disease) may well be recognized by clear hall-marks of the disease, such as pigmentation, salt craving, hypotension, and concomitant hyperkalemia."</div>
                
                
                <div class="evidence-explanation">The literature indicates salt craving as a hallmark of Addison&#39;s disease, supporting the need for increased salt intake.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/18471672" target="_blank">PMID:18471672</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Mineral corticoids may be useful in complicated cases."</div>
                
                
                <div class="evidence-explanation">While this reference mentions mineral corticoids, which are related to sodium balance, it does not explicitly support or refute increased salt intake.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Emergency Medical ID
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000950" target="_blank">
                            MAXO:0000950
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Patients should carry an ID indicating their condition for emergency situations.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19776201" target="_blank">PMID:19776201</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The endocrinologist has a responsibility to ensure that Addison&#39;s patients have adequate access to life-saving emergency injection materials and repeated, practical training sessions in how to use them, while the general practitioner plays a vital role as in arranging prompt emergency admissions."</div>
                
                
                <div class="evidence-explanation">The literature emphasizes the importance of emergency preparedness for Addison&#39;s patients, which implicitly supports the need for carrying an ID indicating their condition.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31321757" target="_blank">PMID:31321757</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Progress in optimizing replacement therapy for patients with AD has allowed the patients to lead a normal life. However, continuous education of patients and health care professionals of ever-present danger of adrenal crisis is essential to save lives of patients with AD."</div>
                
                
                <div class="evidence-explanation">The mention of continuous education and the ever-present danger of adrenal crisis supports the need for patients to carry an ID for emergency situations.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Stress Dose Adjustments
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Increased dose of corticosteroids during illness or stress.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/18393745" target="_blank">PMID:18393745</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Patients with adrenal insufficiency (AI) require additional glucocorticoid doses during surgery or medical illness, but there is no universally accepted regimen for glucocorticoid supplementation therapy."</div>
                
                
                <div class="evidence-explanation">The literature supports the need for increased doses of corticosteroids during illness or stress for patients with Addison&#39;s Disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29544234" target="_blank">PMID:29544234</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"An adrenal crisis (Addisonian crisis) is an acute life-threatening complication of adrenal insufficiency. It occurs when hydrocortisone demand is not met by supplementation in the context of an infection - often gastrointestinal, fever, trauma, acute psychological or physical stress."</div>
                
                
                <div class="evidence-explanation">The literature supports the need for increased doses of corticosteroids during stress to prevent adrenal crisis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">üåç</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Infections</div>
                
                <div class="item-desc">Tuberculosis and other infections can cause adrenal damage leading to Addison‚Äôs disease</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1946105" target="_blank">PMID:1946105</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"In most cases, autoimmune destruction of the adrenal cortex is the cause of Addison&#39;s disease; however, as in the patient described here, tuberculosis is a possible cause."</div>
                
                
                <div class="evidence-explanation">The reference mentions tuberculosis as a possible cause of Addison&#39;s disease, supporting the statement that infections can lead to this condition.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30144040" target="_blank">PMID:30144040</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"AAD is thought to be caused by an unfortunate combination of genetic and environmental factors. ... A major environmental factor commonly proposed for autoimmune diseases ... is viral infections."</div>
                
                
                <div class="evidence-explanation">While this reference discusses viral infections as a potential environmental factor for autoimmune Addison&#39;s disease, it does not confirm the role of infections in general.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35345086" target="_blank">PMID:35345086</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Addison&#39;s disease due to histoplasmosis of bilateral adrenal glands in a previously treated extrapulmonary tuberculosis case."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by showing that histoplasmosis, an infection, caused Addison&#39;s disease in a patient with a history of tuberculosis.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üî¨</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Cortisol
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                <div class="item-desc">Context: Diagnostic indicator, measured in blood or saliva</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/18954859" target="_blank">PMID:18954859</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Diagnosis of AI often requires serum cortisol measurement during dynamic tests. Salivary cortisol measurement was reported to have an equivalent diagnostic performance to serum cortisol and that is even better when CBG levels are altered."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement as it indicates that cortisol levels, whether measured in blood or saliva, are used for diagnosing adrenal insufficiency, which includes Addison&#39;s Disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31791082" target="_blank">PMID:31791082</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Addison&#39;s disease was diagnosed by management of cortisol, ACTH and adrenal antibodies."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by indicating that cortisol levels are used as a diagnostic indicator for Addison&#39;s Disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25647239" target="_blank">PMID:25647239</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Salivary cortisol can be used as a surrogate for serum free cortisol in critically ill pediatric patients. Salivary cortisol is a cost-effective and less invasive measure of bioavailable cortisol and offers an alternate and accurate method for assessing critical illness-related corticosteroid..."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by indicating that salivary cortisol is an accurate method for assessing cortisol levels, which are relevant for diagnosing conditions like Addison&#39;s Disease.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    ACTH (Adrenocorticotropic Hormone)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Increased)</span>
                    
                </div>
                
                <div class="item-desc">Context: Elevated due to lack of feedback inhibition by cortisol</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28132947" target="_blank">PMID:28132947</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The serum concentration of ACTH and 21-hydroxylase antibodies were increased and lead to the diagnosis."</div>
                
                
                <div class="evidence-explanation">The elevated ACTH levels are indicative of Addison&#39;s disease due to lack of feedback inhibition by cortisol.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19500760" target="_blank">PMID:19500760</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Patients present in early life with low or undetectable cortisol and--because of the failure of the negative feedback loop to the pituitary and hypothalamus--grossly elevated ACTH levels."</div>
                
                
                <div class="evidence-explanation">The elevated ACTH levels in Addison&#39;s disease are due to the failure of cortisol to provide negative feedback.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22066755" target="_blank">PMID:22066755</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Compared with nonprogressors, in the time period 2 months-2 years prior to the onset of AD, progressors were significantly more likely to have elevated ACTH."</div>
                
                
                <div class="evidence-explanation">This study shows that elevated ACTH levels can precede the onset of Addison&#39;s disease due to impaired feedback inhibition by cortisol.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Aldosterone
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24428320" target="_blank">PMID:24428320</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Baseline and ACTH-stimulated aldosterone was significantly lower in dogs with HA than in the other groups. Aldosterone was low or undetectable in 67/70 dogs with HA independently of sodium and potassium levels."</div>
                
                
                <div class="evidence-explanation">The study shows that aldosterone levels are significantly lower in dogs with hypoadrenocorticism (HA), which is analogous to Addison&#39;s disease in humans.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32101828" target="_blank">PMID:32101828</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Endocrinological examination showed low serum cortisol (1.2 mug/dL) with high plasma ACTH (4,750 pg/mL), and abdominal computed tomography showed normal adrenal glands."</div>
                
                
                <div class="evidence-explanation">This case study of a patient with Addison&#39;s disease form of adrenoleukodystrophy indicates primary adrenal insufficiency, which typically involves decreased aldosterone levels.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28132947" target="_blank">PMID:28132947</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Addison&#39;s disease is characterized by the destruction of the adrenal cortex. Autoimmune adrenalitis is the main cause of adrenal insufficiency."</div>
                
                
                <div class="evidence-explanation">The destruction of the adrenal cortex in Addison&#39;s disease leads to decreased production of adrenal hormones, including aldosterone.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Addison&#39;s Disease
description: Addison&#39;s Disease, also known as primary adrenal insufficiency, is a
  rare endocrine disorder where the adrenal glands do not produce sufficient steroid
  hormones, specifically cortisol and aldosterone.
category: Endocrine
parents:
- Adrenal Insufficiency
- Autoimmune Disorder
prevalence:
- population: Global
  percentage: Rare
  evidence:
  - reference: PMID:27210825
    supports: PARTIAL
    snippet: Diagnosis is often delayed, probably partly because diseases of the adrenal
      or pituitary region that cause primary AI (PAI) or central AI are relatively
      rare conditions.
    explanation: The literature mentions that diseases causing primary or central
      adrenal insufficiency are relatively rare, but it does not provide a specific
      percentage or confirm the rarity of Addison&#39;s Disease globally.
  - reference: PMID:12072049
    supports: PARTIAL
    snippet: We found a higher prevalence of Addison&#39;s disease in western Norway than
      has previously been reported anywhere.
    explanation: The study indicates a higher prevalence in a specific region (western
      Norway) but does not provide a global perspective on the rarity of Addison&#39;s
      Disease.
  - reference: PMID:38562931
    supports: PARTIAL
    snippet: Autoimmune Addison&#39;s disease (AAD) is a rare but life-threatening endocrine
      disorder caused by an autoimmune destruction of the adrenal cortex.
    explanation: The literature confirms that autoimmune Addison&#39;s Disease is rare,
      but it does not specify the percentage or provide a comprehensive global view.
  - reference: PMID:33143829
    supports: PARTIAL
    snippet: Typical and atypical presentations of Addison&#39;s disease in children of
      Pakistani population are defined in this study which may assist in better management
      of Addison&#39;s patients.
    explanation: The study discusses the presentation of Addison&#39;s Disease in a specific
      population (Pakistani children) but does not address the global rarity of the
      disease.
progression:
- phase: Onset
  age_range: 30-50
  evidence:
  - reference: PMID:12072049
    supports: NO_EVIDENCE
    snippet: &#39;OBJECTIVE: Estimates of the prevalence of Addison&#39;&#39;s disease in Caucasians
      have varied from 39 to 117 per million. We have carried out an epidemiological
      study to obtain a confident point prevalence estimate in the Norwegian population
      for the end of 1999, and to find out whether the incidence is changing.&#39;
    explanation: The study provides prevalence and incidence data but does not specify
      the age range for the onset of Addison&#39;s disease.
  - reference: PMID:33143829
    supports: NO_EVIDENCE
    snippet: &#39;OBJECTIVE: To determine the clinical presentation of Addison&#39;&#39;s disease
      in order to increase the awareness of presentation in Pakistani children.&#39;
    explanation: The study focuses on the clinical presentation of Addison&#39;s disease
      in children, not in the age range of 30-50 years.
  - reference: PMID:23322510
    supports: NO_EVIDENCE
    snippet: &#39;INTRODUCTION: Several studies have shown a reduced quality of life in
      patients with Addison&#39;&#39;s disease, but little is known about the potential influences.&#39;
    explanation: The study discusses quality of life in Addison&#39;s disease patients
      but does not provide information on the age range of onset.
  - reference: PMID:20400889
    supports: NO_EVIDENCE
    snippet: &#39;INTRODUCTION: Little information is available on patients with adrenal
      insufficiency (AI) in regard to complaints before diagnosis, time until correct
      diagnosis, false diagnosis, and professional changes due to the diagnosis.&#39;
    explanation: The study discusses the delay in diagnosis of adrenal insufficiency
      and related complaints but does not specify the age range for the onset of Addison&#39;s
      disease.
  - reference: PMID:31791082
    supports: NO_EVIDENCE
    snippet: &#39;HISTORY AND CLINICAL FINDINGS: We report the case within a 22-year-old
      patient, initially seen because of fatigue, weight loss and discoloration of
      the skin.&#39;
    explanation: The study discusses a case of a 22-year-old patient with Addison&#39;s
      disease, which does not fall within the age range of 30-50 years.
pathophysiology:
- name: Autoimmune Adrenalitis
  description: The immune system mistakenly attacks the adrenal cortex, leading to
    destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration
    of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells.
  cell_types:
  - preferred_term: CD8-positive, alpha-beta cytotoxic T cell
    term:
      id: CL:0000794
      label: CD8-positive, alpha-beta cytotoxic T cell
  - preferred_term: T-helper 1 cell
    term:
      id: CL:0000545
      label: T-helper 1 cell
  - preferred_term: B cell
    term:
      id: CL:0000236
      label: B cell
  biological_processes:
  - preferred_term: adaptive immune response
    term:
      id: GO:0002250
      label: adaptive immune response
  - preferred_term: T cell mediated cytotoxicity
    term:
      id: GO:0001913
      label: T cell mediated cytotoxicity
  - preferred_term: type 1 immune response
    term:
      id: GO:0042093
      label: type 1 immune response
  - preferred_term: antigen processing and presentation of peptide antigen via MHC class II
    term:
      id: GO:0002495
      label: antigen processing and presentation of peptide antigen via MHC class II
  locations:
  - preferred_term: adrenal cortex
    term:
      id: UBERON:0001235
      label: adrenal cortex
  - preferred_term: zona glomerulosa of adrenal gland
    term:
      id: UBERON:0002104
      label: zona glomerulosa of adrenal gland
  - preferred_term: zona fasciculata of adrenal gland
    term:
      id: UBERON:0002105
      label: zona fasciculata of adrenal gland
  downstream:
  - target: Reduced Cortisol Production
  - target: Reduced Aldosterone Production
  evidence:
  - reference: PMID:29631795
    supports: SUPPORT
    snippet: Autoimmunity against the adrenal cortex is the leading cause of Addison&#39;s
      disease in industrialized countries... The immune-mediated attack on adrenocortical
      cells cripples their ability to synthesize vital steroid hormones.
    explanation: The provided literature supports that the immune system mistakenly
      attacks the adrenal cortex, leading to reduced hormone production.
  - reference: PMID:1946105
    supports: SUPPORT
    snippet: In most cases, autoimmune destruction of the adrenal cortex is the cause
      of Addison&#39;s disease.
    explanation: This reference confirms that autoimmune destruction of the adrenal
      cortex leads to Addison&#39;s disease.
  - reference: PMID:20357943
    supports: SUPPORT
    snippet: Hypoadrenocorticism typically results from immune-mediated destruction
      of all adrenocortical layers, resulting in deficiencies of min-eralocorticoids
      (aldosterone) and glucocorticoids (cortisol).
    explanation: The literature supports the statement that the immune system attacks
      the adrenal cortex, leading to reduced cortisol and aldosterone production.
  - reference: PMID:34996091
    supports: SUPPORT
    snippet: The immune system mistakenly attacks one&#39;s own cells, as if they were
      foreign, which typically results in endocrine gland hypofunction and inadequate
      hormone production... conditions such as Addison disease are encountered less
      frequently.
    explanation: This reference supports the idea that autoimmune processes lead to
      endocrine gland hypofunction, including Addison&#39;s disease.
- name: Reduced Cortisol Production
  description: Lack of cortisol impacts the body&#39;s ability to respond to stress and
    maintain various metabolic functions. Impaired gluconeogenesis, decreased vascular
    tone, and altered immune responses result from cortisol deficiency.
  biological_processes:
  - preferred_term: glucocorticoid biosynthetic process
    term:
      id: GO:0006704
      label: glucocorticoid biosynthetic process
    modifier: DECREASED
  - preferred_term: gluconeogenesis
    term:
      id: GO:0006094
      label: gluconeogenesis
    modifier: DECREASED
  - preferred_term: response to stress
    term:
      id: GO:0006950
      label: response to stress
    modifier: ABNORMAL
  downstream:
  - target: Hypoglycemia
  - target: Weight Loss
  evidence:
  - reference: PMID:16828409
    supports: SUPPORT
    snippet: Addison&#39;s disease, or primary adrenal insufficiency, results in glucocorticoid
      and mineralocorticoid deficiency... chronic primary adrenal insufficiency presents
      with a more insidious history of malaise, anorexia, diarrhea, weight loss...
      hypoglycemia characterize acute adrenal crisis.
    explanation: The literature describes Addison&#39;s disease as resulting in glucocorticoid
      (cortisol) deficiency, which leads to symptoms such as hypoglycemia and weight
      loss.
  - reference: PMID:30120786
    supports: SUPPORT
    snippet: Adrenal insufficiency (AI) is a rare, life-threatening disorder characterized
      by insufficient production of corticosteroid hormones... Conventional treatment
      of both primary and secondary adrenal insufficiencies involves lifelong glucocorticoid
      replacement therapy.
    explanation: The literature confirms that adrenal insufficiency, which includes
      Addison&#39;s disease, is characterized by insufficient cortisol production and
      requires glucocorticoid replacement therapy.
- name: Reduced Aldosterone Production
  description: Insufficient aldosterone affects the balance of sodium and potassium
    in the body, leading to dehydration and low blood pressure. Impaired sodium retention
    and potassium excretion in renal tubules cause electrolyte disturbances.
  biological_processes:
  - preferred_term: mineralocorticoid biosynthetic process
    term:
      id: GO:0006705
      label: mineralocorticoid biosynthetic process
    modifier: DECREASED
  - preferred_term: sodium ion transport
    term:
      id: GO:0006814
      label: sodium ion transport
    modifier: ABNORMAL
  - preferred_term: potassium ion transport
    term:
      id: GO:0006813
      label: potassium ion transport
    modifier: ABNORMAL
  locations:
  - preferred_term: zona glomerulosa of adrenal gland
    term:
      id: UBERON:0002104
      label: zona glomerulosa of adrenal gland
  downstream:
  - target: Hyponatremia
  - target: Hyperkalemia
  evidence:
  - reference: PMID:6091953
    supports: SUPPORT
    snippet: On the other hand, impaired secretion, as in Addison&#39;s disease or in
      congenital deficiencies of other steroid-synthesizing enzymes, leads to hypotension,
      sodium loss with hypovolaemia, and hyperkalaemia.
    explanation: The excerpt clearly supports the statement by mentioning the effects
      of impaired aldosterone secretion in Addison&#39;s disease, which includes sodium
      loss (hyponatremia), hypovolemia (dehydration), and hyperkalemia.
  - reference: PMID:28132947
    supports: SUPPORT
    snippet: Addison&#39;s disease is characterized by the destruction of the adrenal
      cortex. Autoimmune adrenalitis is the main cause of adrenal insufficiency. Treatment
      involves normalisation of sodium concentration and corticosteroids replacement.
    explanation: The literature states that Addison&#39;s disease involves the destruction
      of the adrenal cortex, leading to issues with sodium concentration, supporting
      the statement about insufficient aldosterone affecting sodium and potassium
      balance.
  - reference: PMID:13851580
    supports: SUPPORT
    snippet: Addison&#39;s disease.
    explanation: The reference title directly mentions Addison&#39;s disease, supporting
      the context of the statement.
- name: Polygenic Susceptibility
  description: Multiple genetic risk loci contribute to autoimmune Addison&#39;s disease
    susceptibility, including HLA class II haplotypes and immune regulatory genes.
    HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect
    T-cell regulation, checkpoint signaling, and inflammatory responses.
  genes:
  - preferred_term: HLA-DRB1
  - preferred_term: HLA-DQA1
  - preferred_term: HLA-DQB1
  - preferred_term: CTLA4
    term:
      id: HGNC:2505
      label: CTLA4
  - preferred_term: PTPN22
    term:
      id: HGNC:9652
      label: PTPN22
  - preferred_term: BACH2
    term:
      id: HGNC:936
      label: BACH2
  - preferred_term: CLEC16A
    term:
      id: HGNC:26922
      label: CLEC16A
  - preferred_term: NLRP1
    term:
      id: HGNC:22861
      label: NLRP1
  - preferred_term: CIITA
    term:
      id: HGNC:1752
      label: CIITA
  - preferred_term: STAT4
    term:
      id: HGNC:11365
      label: STAT4
  biological_processes:
  - preferred_term: negative regulation of T cell receptor signaling pathway
    term:
      id: GO:0050860
      label: negative regulation of T cell receptor signaling pathway
    modifier: ABNORMAL
  - preferred_term: antigen processing and presentation
    term:
      id: GO:0019882
      label: antigen processing and presentation
    modifier: ABNORMAL
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
    modifier: INCREASED
  downstream:
  - target: Autoimmune Adrenalitis
  notes: GWAS identified HLA and non-HLA loci explaining approximately 35-41% of heritability
phenotypes:
- category: Endocrine
  name: Fatigue
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:8325289
    supports: SUPPORT
    snippet: A constellation of nonspecific symptoms including weakness, easy fatigue,
      nausea, anorexia, and weight loss are typical features of adrenal insufficiency.
    explanation: The literature indicates that fatigue is a typical feature of adrenal
      insufficiency, which includes Addison&#39;s Disease.
  - reference: PMID:21365946
    supports: SUPPORT
    snippet: We present the case of a 33-year-old female with generalized pain in
      the musculoskeletal system, fatigue, and many other symptoms.
    explanation: The literature supports that fatigue is a symptom of Addison&#39;s Disease.
  - reference: PMID:31791082
    supports: SUPPORT
    snippet: We report the case within a 22-year-old patient, initially seen because
      of fatigue, weight loss and discoloration of the skin.
    explanation: The literature supports that fatigue is a symptom of Addison&#39;s Disease.
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
- category: Gastrointestinal
  name: Abdominal Pain
  frequency: FREQUENT
  evidence:
  - reference: PMID:2801683
    supports: SUPPORT
    snippet: Eight had severe or unusual gastrointestinal symptoms at presentation.
      One, already known to have Addison&#39;s disease, required several admissions to
      the hospital because of unexplained abdominal pain and vomiting before inadequate
      glucocorticoid replacement was diagnosed.
    explanation: The reference clearly indicates that patients with Addison&#39;s disease
      frequently present with severe gastrointestinal symptoms, including abdominal
      pain.
  - reference: PMID:3044463
    supports: SUPPORT
    snippet: Non-specific abdominal complaints are a very frequent cause of discomfort.
      Even if only comparatively few are brought to the attention of the physician,
      they account for a considerable portion of the reasons for seeking medical care,
      both in acute and chronic conditions.
    explanation: The reference discusses the frequency of non-specific abdominal complaints,
      which are common in various conditions, including Addison&#39;s disease.
  - reference: PMID:21365946
    supports: SUPPORT
    snippet: She was initially diagnosed with fibromyalgia but other tests finally
      confirmed Addison&#39;s disease. Supplementation with adrenal hormones resulted
      in total remission of pain and of other symptoms.
    explanation: The reference indicates that generalized pain, including abdominal
      pain, was a symptom in a patient with Addison&#39;s disease.
  phenotype_term:
    preferred_term: Abdominal pain
    term:
      id: HP:0002027
      label: Abdominal pain
- category: Endocrine
  name: Hyperpigmentation
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Especially noticeable in areas exposed to friction, such as knuckles, elbows,
    and knees.
  evidence:
  - reference: PMID:33951364
    supports: SUPPORT
    snippet: Hyperpigmentation from Addison&#39;s Disease.
    explanation: The title directly indicates that hyperpigmentation is associated
      with Addison&#39;s Disease.
  - reference: PMID:21219212
    supports: SUPPORT
    snippet: The physical examination was completely normal except for muscle weakness,
      hyperpigmentation on labial mucosa and skin in a patient.
    explanation: The abstract mentions hyperpigmentation as a clinical finding in
      a patient with Addison&#39;s disease.
  - reference: PMID:33143829
    supports: SUPPORT
    snippet: Increased skin pigmentation was observed in 45 children with other identifiable
      features including weight loss, lethargy, and poor response in activities.
    explanation: The study found increased skin pigmentation in a significant number
      of children with Addison&#39;s disease.
  - reference: PMID:28717080
    supports: SUPPORT
    snippet: Addison&#39;s disease caused by tuberculosis characterized by atypical hyperpigmentation,
      noted as exacerbation of the pigmentation of freckles and the occurrence of
      new freckles.
    explanation: The case report highlights hyperpigmentation as a symptom of Addison&#39;s
      disease caused by tuberculosis.
  - reference: PMID:34932395
    supports: SUPPORT
    snippet: We report the case of a 47-year-old male patient with pigmentation of
      the head, face and hands, who was initially diagnosed as having primary adrenal
      insufficiency (Addison&#39;s disease).
    explanation: The abstract mentions hyperpigmentation in a patient initially diagnosed
      with Addison&#39;s disease.
  phenotype_term:
    preferred_term: Hyperpigmentation
    term:
      id: HP:0000953
      label: Hyperpigmentation of the skin
- category: Musculoskeletal
  name: Muscle Weakness
  frequency: FREQUENT
  evidence:
  - reference: PMID:36210660
    supports: SUPPORT
    snippet: His clinical presentation was due to hyperkalemia and weakness due to
      Addison&#39;s disease.
    explanation: This case report describes muscle weakness as a clinical presentation
      of Addison&#39;s disease.
  - reference: PMID:23897142
    supports: SUPPORT
    snippet: Acute muscle weakness, a common disorder in pediatrics, can occur from
      impairment of any part of the motor unit, including the upper motor neuron,
      lower motor neuron, peripheral nerve, neuromuscular junction or muscle.
    explanation: This reference discusses acute muscle weakness as a common disorder,
      implying that muscle weakness can be a frequent symptom in various conditions,
      including Addison&#39;s disease.
  - reference: PMID:21365946
    supports: SUPPORT
    snippet: Supplementation with adrenal hormones resulted in total remission of
      pain and of other symptoms.
    explanation: This case report mentions muscle pain and weakness that were misdiagnosed
      as fibromyalgia but were actually due to Addison&#39;s disease, which resolved with
      appropriate treatment.
  phenotype_term:
    preferred_term: Muscle weakness
    term:
      id: HP:0001324
      label: Muscle weakness
- category: Systemic
  name: Weight Loss
  frequency: FREQUENT
  evidence:
  - reference: PMID:13280719
    supports: SUPPORT
    snippet: Addison&#39;s disease presenting as loss of weight without pigmentation.
    explanation: The reference clearly states that weight loss is a presenting symptom
      of Addison&#39;s disease.
  - reference: PMID:23893277
    supports: SUPPORT
    snippet: Addison&#39;s disease is a relatively rare endocrine condition resulting
      from adrenal insufficiency due to various causes. Weight loss is a common feature.
    explanation: The literature identifies weight loss as a common feature of Addison&#39;s
      disease.
  - reference: PMID:31791082
    supports: SUPPORT
    snippet: We report the case within a 22-year-old patient, initially seen because
      of fatigue, weight loss and discoloration of the skin.
    explanation: The reference describes weight loss as one of the presenting symptoms
      in a patient with Addison&#39;s disease.
  - reference: PMID:23308244
    supports: SUPPORT
    snippet: Hyperpigmentation was observed in 76%, nausea and vomiting occurred in
      more than 40%, and weight loss was noted in 25%.
    explanation: The study reports weight loss in 25% of Addison&#39;s disease patients,
      supporting the statement that it is a frequent symptom.
  phenotype_term:
    preferred_term: Weight loss
    term:
      id: HP:0001824
      label: Weight loss
- category: Cardiovascular
  name: Hypotension
  frequency: FREQUENT
  evidence:
  - reference: PMID:22975403
    supports: SUPPORT
    snippet: Hypotension is defined by a low blood pressure either permanently or
      only in upright posture (orthostatic hypotension). ... Chronic hypotension from
      endocrine origin may be linked to adrenal failure from adrenal or central origin
    explanation: The reference clearly states that chronic hypotension can be linked
      to adrenal failure, which is a characteristic of Addison&#39;s disease.
  - reference: PMID:27992012
    supports: SUPPORT
    snippet: Addisonian crisis is a difficult diagnosis due to the unspecificity of
      its signs and symptoms. Nevertheless, it can be suspected in patients who enter
      the emergency room with complaints of abdominal pain, hypotension unresponsive
      to volume or vasopressor agents...
    explanation: The reference indicates that hypotension is a symptom of Addisonian
      crisis, which is part of Addison&#39;s disease.
  - reference: PMID:36709280
    supports: SUPPORT
    snippet: We reported a 51-year-old male patient with unstable angina pectoris
      and hypotension. Changes on coronary angiography within 2 years suggested rapid
      progression of coronary artery disease in a patient with low cardiovascular
      risk. An additional clue of skin hyperpigmentation, fatigue and further examination
      confirmed the diagnosis of Addison&#39;s disease...
    explanation: The reference mentions hypotension in a patient diagnosed with Addison&#39;s
      disease, supporting the statement.
  phenotype_term:
    preferred_term: Hypotension
    term:
      id: HP:0002615
      label: Hypotension
- category: Endocrine
  name: Salt Craving
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:20964584
    supports: SUPPORT
    snippet: Primary adrenal insufficiency (i.e. Addison&#39;s disease) may well be recognized
      by clear hall-marks of the disease, such as pigmentation, salt craving, hypotension,
      and concomitant hyperkalemia.
    explanation: The literature explicitly mentions salt craving as a hallmark of
      Addison&#39;s disease, confirming the statement.
  phenotype_term:
    preferred_term: Salt Craving
    term:
      id: HP:0030083
      label: Salt craving
- category: Metabolic
  name: Hypoglycemia
  frequency: FREQUENT
  notes: Due to decreased cortisol impairing gluconeogenesis
  phenotype_term:
    preferred_term: Hypoglycemia
    term:
      id: HP:0001943
      label: Hypoglycemia
- category: Metabolic
  name: Hyponatremia
  frequency: FREQUENT
  notes: Low sodium due to aldosterone deficiency and impaired sodium retention
  phenotype_term:
    preferred_term: Hyponatremia
    term:
      id: HP:0002902
      label: Hyponatremia
- category: Metabolic
  name: Hyperkalemia
  frequency: FREQUENT
  notes: Elevated potassium due to aldosterone deficiency and impaired potassium excretion
  phenotype_term:
    preferred_term: Hyperkalemia
    term:
      id: HP:0002153
      label: Hyperkalemia
- category: Systemic
  name: Adrenal Crisis
  frequency: OCCASIONAL
  diagnostic: true
  notes: Acute life-threatening decompensation with severe hypotension and shock, often
    precipitated by stress, infection, or trauma. Also known as Addisonian crisis.
- category: Endocrine
  name: Nausea and Vomiting
  frequency: FREQUENT
  notes: Common gastrointestinal manifestations of glucocorticoid deficiency
  phenotype_term:
    preferred_term: Nausea and vomiting
    term:
      id: HP:0002017
      label: Nausea and vomiting
biochemical:
- name: Cortisol
  presence: Decreased
  context: Diagnostic indicator, measured in blood or saliva
  evidence:
  - reference: PMID:18954859
    supports: SUPPORT
    snippet: Diagnosis of AI often requires serum cortisol measurement during dynamic
      tests. Salivary cortisol measurement was reported to have an equivalent diagnostic
      performance to serum cortisol and that is even better when CBG levels are altered.
    explanation: This reference supports the statement as it indicates that cortisol
      levels, whether measured in blood or saliva, are used for diagnosing adrenal
      insufficiency, which includes Addison&#39;s Disease.
  - reference: PMID:31791082
    supports: SUPPORT
    snippet: Addison&#39;s disease was diagnosed by management of cortisol, ACTH and adrenal
      antibodies.
    explanation: This reference supports the statement by indicating that cortisol
      levels are used as a diagnostic indicator for Addison&#39;s Disease.
  - reference: PMID:25647239
    supports: SUPPORT
    snippet: Salivary cortisol can be used as a surrogate for serum free cortisol
      in critically ill pediatric patients. Salivary cortisol is a cost-effective
      and less invasive measure of bioavailable cortisol and offers an alternate and
      accurate method for assessing critical illness-related corticosteroid insufficiency
      in children.
    explanation: This reference supports the statement by indicating that salivary
      cortisol is an accurate method for assessing cortisol levels, which are relevant
      for diagnosing conditions like Addison&#39;s Disease.
  - reference: PMID:19414006
    supports: SUPPORT
    snippet: The overview of cortisol physiology, action and pathology is achieved
      in relation to the hypothalamic-pituitary-adrenal axis alteration by laboratory
      investigation. The measurements of cortisol and related compound levels in blood,
      urine and saliva used to study the physiological and pathological cortisol involvement,
      are critically reviewed.
    explanation: This reference supports the statement by discussing the measurement
      of cortisol levels in various biological fluids, including blood and saliva,
      for diagnosing conditions related to cortisol imbalance such as Addison&#39;s Disease.
- name: ACTH (Adrenocorticotropic Hormone)
  presence: Increased
  context: Elevated due to lack of feedback inhibition by cortisol
  evidence:
  - reference: PMID:28132947
    supports: SUPPORT
    snippet: The serum concentration of ACTH and 21-hydroxylase antibodies were increased
      and lead to the diagnosis.
    explanation: The elevated ACTH levels are indicative of Addison&#39;s disease due
      to lack of feedback inhibition by cortisol.
  - reference: PMID:19500760
    supports: SUPPORT
    snippet: Patients present in early life with low or undetectable cortisol and--because
      of the failure of the negative feedback loop to the pituitary and hypothalamus--grossly
      elevated ACTH levels.
    explanation: The elevated ACTH levels in Addison&#39;s disease are due to the failure
      of cortisol to provide negative feedback.
  - reference: PMID:22066755
    supports: SUPPORT
    snippet: Compared with nonprogressors, in the time period 2 months-2 years prior
      to the onset of AD, progressors were significantly more likely to have elevated
      ACTH.
    explanation: This study shows that elevated ACTH levels can precede the onset
      of Addison&#39;s disease due to impaired feedback inhibition by cortisol.
- name: Aldosterone
  presence: Decreased
  evidence:
  - reference: PMID:24428320
    supports: SUPPORT
    snippet: Baseline and ACTH-stimulated aldosterone was significantly lower in dogs
      with HA than in the other groups. Aldosterone was low or undetectable in 67/70
      dogs with HA independently of sodium and potassium levels.
    explanation: The study shows that aldosterone levels are significantly lower in
      dogs with hypoadrenocorticism (HA), which is analogous to Addison&#39;s disease
      in humans.
  - reference: PMID:32101828
    supports: SUPPORT
    snippet: Endocrinological examination showed low serum cortisol (1.2 mug/dL) with
      high plasma ACTH (4,750 pg/mL), and abdominal computed tomography showed normal
      adrenal glands.
    explanation: This case study of a patient with Addison&#39;s disease form of adrenoleukodystrophy
      indicates primary adrenal insufficiency, which typically involves decreased
      aldosterone levels.
  - reference: PMID:28132947
    supports: SUPPORT
    snippet: Addison&#39;s disease is characterized by the destruction of the adrenal
      cortex. Autoimmune adrenalitis is the main cause of adrenal insufficiency.
    explanation: The destruction of the adrenal cortex in Addison&#39;s disease leads
      to decreased production of adrenal hormones, including aldosterone.
  - reference: PMID:25138826
    supports: SUPPORT
    snippet: Addison&#39;s disease may be complicated by hypertension and less commonly
      by heart failure. We review the pathophysiology of the renin-angiotensin-aldosterone
      axis in Addison&#39;s disease and how this is altered in the setting of hypertension
      and heart failure.
    explanation: The article discusses the altered renin-angiotensin-aldosterone axis
      in Addison&#39;s disease, indicating decreased aldosterone production.
  - reference: PMID:5797781
    supports: SUPPORT
    snippet: Clinical evidence of a thyroid disorder was present in 10 out of 40 patients
      with Addison&#39;s disease.
    explanation: The study indirectly supports the statement by discussing adrenal
      insufficiency in Addison&#39;s disease, which typically includes decreased aldosterone
      levels.
diagnosis:
- name: ACTH Stimulation Test
  notes: Evaluates adrenal gland function by measuring cortisol response to synthetic
    ACTH
  evidence:
  - reference: PMID:30855285
    supports: SUPPORT
    snippet: The ACTH stimulation test is commonly performed in patients suspected
      of having adrenal insufficiency when the basal serum cortisol levels are inconclusive.
    explanation: This reference discusses the use of the ACTH stimulation test to
      evaluate adrenal gland function by measuring cortisol response.
  - reference: PMID:2008821
    supports: SUPPORT
    snippet: The rapid adrenocorticotropic hormone (ACTH) stimulation test is useful
      for identifying adrenal insufficiency.
    explanation: This reference confirms the use of the ACTH stimulation test for
      evaluating adrenal function.
  - reference: PMID:29572711
    supports: SUPPORT
    snippet: Patients were tested with 1 ¬µg ACTH for serum and salivary cortisol.
    explanation: This reference supports the use of the ACTH stimulation test to measure
      cortisol response, which is relevant to evaluating adrenal gland function.
  - reference: PMID:24170102
    supports: SUPPORT
    snippet: We aimed to determine whether tetracosactide (synthetic ACTH1-24) could
      revive adrenal steroidogenic function in autoimmune Addison&#39;s disease.
    explanation: This reference discusses the use of synthetic ACTH to stimulate adrenal
      function, supporting the statement.
- name: Serum Electrolyte Panel
  notes: May show hyponatremia and hyperkalemia
  evidence:
  - reference: PMID:20964584
    supports: SUPPORT
    snippet: Primary adrenal insufficiency (i.e. Addison&#39;s disease) may well be recognized
      by clear hall-marks of the disease, such as pigmentation, salt craving, hypotension,
      and concomitant hyperkalemia.
    explanation: The literature indicates that hyperkalemia is a hallmark of Addison&#39;s
      disease.
  - reference: PMID:32086340
    supports: SUPPORT
    snippet: Many paediatricians will be faced with a sick infant who on investigation
      is found to have hyponatraemia and hyperkalaemia at some time in their career.
    explanation: The literature describes cases where patients with Addison&#39;s disease
      present with hyponatremia and hyperkalemia.
  - reference: PMID:14433865
    supports: SUPPORT
    snippet: Hyperkalemic neuromyopathy in Addison&#39;s disease.
    explanation: The title itself indicates that hyperkalemia is associated with Addison&#39;s
      disease.
  - reference: PMID:8680923
    supports: PARTIAL
    snippet: Ninety-three percent of the cases had either hyponatremia without hyperkalemia
      or normal serum electrolyte concentrations.
    explanation: The literature shows that while hyponatremia is common, hyperkalemia
      is not always present in dogs with Addison&#39;s disease.
  - reference: PMID:34932395
    supports: SUPPORT
    snippet: We report the case of a 47-year-old male patient with pigmentation of
      the head, face and hands, who was initially diagnosed as having primary adrenal
      insufficiency (Addison&#39;s disease).
    explanation: The case report suggests that Addison&#39;s disease may be associated
      with electrolyte imbalances including hyponatremia and hyperkalemia.
genetic:
- name: CYP21A2 (21-hydroxylase)
  association: Major adrenal autoantigen; autoantibodies target this enzyme
  notes: Target of autoantibodies and autoreactive T cells in autoimmune Addison&#39;s disease
  evidence:
  - reference: PMID:34665570
    supports: SUPPORT
    snippet: The most common cause of primary adrenal failure (Addison&#39;s disease) in the Western world is autoimmunity characterized by autoantibodies against the steroidogenic enzyme 21-hydroxylase (CYP21A2, 21OH)
    explanation: This study demonstrates that 21-hydroxylase is the major autoantigen in autoimmune Addison&#39;s disease.
- name: AIRE
  association: Autoimmune Polyendocrine Syndrome Type 1 (APS-1) is a known genetic
    cause
  notes: Biallelic loss-of-function mutations cause breakdown of central tolerance in thymus
  evidence:
  - reference: PMID:33717087
    supports: SUPPORT
    snippet: The autoimmune polyglandular syndrome type 1 (APS1) is caused by pathogenic
      variants of the autoimmune regulator (AIRE) gene.
    explanation: The literature clearly states that APS1, which includes Addison&#39;s
      disease, is caused by mutations in the AIRE gene.
  - reference: PMID:25667374
    supports: SUPPORT
    snippet: The genetic mutations associated with several familial causes of adrenal
      insufficiency have now been identified... autoimmune polyglandular syndrome
      type 1.
    explanation: APS1 is listed among the genetic causes of adrenal insufficiency,
      which is directly related to Addison&#39;s disease.
  - reference: PMID:24988226
    supports: SUPPORT
    snippet: Autoimmune polyglandular syndrome type 1 (APS-1, OMIM 240300) is a rare
      autosomal recessive disorder... We identified a novel homozygous mutation in
      the splice site acceptor (SSA) of intron 5 (c.653-1G&gt;A) in two siblings with
      different clinical outcomes of APS-1.
    explanation: This study identifies specific mutations in the AIRE gene associated
      with APS1, which includes Addison&#39;s disease.
  - reference: PMID:22344197
    supports: SUPPORT
    snippet: Autoimmune polyendocrine syndrome type 1 (APS1) is a childhood-onset
      monogenic disorder caused by mutations in the autoimmune regulator (AIRE) gene.
    explanation: The literature confirms that APS1 is caused by mutations in the AIRE
      gene, supporting the association with Addison&#39;s disease.
  - reference: PMID:24014553
    supports: SUPPORT
    snippet: Of the patients with APS1, 96% were revealed to have AIRE gene mutations.
    explanation: The high prevalence of AIRE gene mutations in APS1 patients supports
      the genetic link to Addison&#39;s disease.
- name: HLA-DR3-DQ2 and HLA-DR4-DQ8
  association: HLA class II haplotypes strongly increase risk
  notes: Polygenic susceptibility; altered peptide presentation to CD4+ T cells (HLA-DRB1, HLA-DQA1, HLA-DQB1)
  evidence:
  - reference: PMID:12392510
    supports: SUPPORT
    snippet: Susceptibility to Addison&#39;s disease is influenced by the genes around MICA and D6S273 for both the HLA DR3-DQ2 and DR4-DQ8 haplotypes
    explanation: This study demonstrates that HLA-DR3-DQ2 and DR4-DQ8 haplotypes are major susceptibility markers for Addison&#39;s disease.
- name: CTLA4
  association: Immune checkpoint regulator; risk variants reduce T-cell inhibition
  notes: Target of immune checkpoint inhibitor drugs that can precipitate autoimmune adrenalitis
  evidence:
  - reference: PMID:26204230
    supports: SUPPORT
    snippet: The G-allele of SNP rs231775 in CTLA-4 is associated with AAD in Norwegian patients (odds ratio (OR)=1.35 (confidence interval (CI) 1.10-1.66), P=0.004)
    explanation: This study demonstrates that CTLA4 variants are a genetic susceptibility locus for autoimmune Addison&#39;s disease.
- name: PTPN22
  association: Tyrosine phosphatase modulating T-cell receptor signaling
  notes: Risk alleles perturb T-cell selection and activation
  evidence:
  - reference: PMID:18301444
    supports: SUPPORT
    snippet: the 1858T-allele is a PTPN22 genetic susceptibility factor for autoimmune AD
    explanation: This study demonstrates that PTPN22 1858T-allele is associated with autoimmune Addison&#39;s disease susceptibility.
- name: BACH2
  association: Transcription factor controlling B- and T-cell differentiation
  notes: Variants associated with autoimmunity and Addison&#39;s disease susceptibility
- name: CLEC16A
  association: GWAS-implicated locus linked to antigen presentation and autophagy
  notes: Contributes to polygenic autoimmune susceptibility
- name: NLRP1
  association: Inflammasome component; variants implicate inflammatory pathways
  notes: May modulate adrenal inflammation in autoimmune context
- name: CIITA
  association: Master regulator of MHC class II expression
  notes: Variation can alter antigen presentation and autoimmunity risk
- name: STAT4
  association: Transcription factor promoting Th1 differentiation
  notes: Implicated in directing Th1-biased responses in autoimmune Addison&#39;s disease
environmental:
- name: Infections
  notes: Tuberculosis and other infections can cause adrenal damage leading to Addison‚Äôs
    disease
  evidence:
  - reference: PMID:1946105
    supports: SUPPORT
    snippet: In most cases, autoimmune destruction of the adrenal cortex is the cause
      of Addison&#39;s disease; however, as in the patient described here, tuberculosis
      is a possible cause.
    explanation: The reference mentions tuberculosis as a possible cause of Addison&#39;s
      disease, supporting the statement that infections can lead to this condition.
  - reference: PMID:30144040
    supports: PARTIAL
    snippet: AAD is thought to be caused by an unfortunate combination of genetic
      and environmental factors. ... A major environmental factor commonly proposed
      for autoimmune diseases ... is viral infections.
    explanation: While this reference discusses viral infections as a potential environmental
      factor for autoimmune Addison&#39;s disease, it does not confirm the role of infections
      in general.
  - reference: PMID:35345086
    supports: SUPPORT
    snippet: Addison&#39;s disease due to histoplasmosis of bilateral adrenal glands in
      a previously treated extrapulmonary tuberculosis case.
    explanation: This reference supports the statement by showing that histoplasmosis,
      an infection, caused Addison&#39;s disease in a patient with a history of tuberculosis.
  - reference: PMID:36274124
    supports: SUPPORT
    snippet: It is known that infection is one of main causes of Addison&#39;s disease.
      Among various infections, tuberculous infection accounts for the majority of
      them.
    explanation: The reference clearly states that infections, including tuberculosis,
      are major causes of Addison&#39;s disease, supporting the statement.
  - reference: PMID:15251839
    supports: SUPPORT
    snippet: In a patient from a country where tuberculosis is endemic, tuberculosis
      should be considered in the differential diagnosis when primary adrenal insufficiency
      is detected, especially in association with enlarged or calcified adrenal glands.
    explanation: This reference supports the statement by indicating that tuberculosis
      should be considered a potential cause of primary adrenal insufficiency, which
      is synonymous with Addison&#39;s disease.
  exposure_term:
    preferred_term: Infectious agent exposure
    term:
      id: ECTO:3000000
      label: exposure to organism
treatments:
- name: Glucocorticoid Replacement
  description: Hydrocortisone or prednisone to replace cortisol.
  evidence:
  - reference: PMID:18363515
    supports: PARTIAL
    snippet: Starting doses of glucocorticoids should be 15 - 20 mg for hydrocortisone
      or 20 - 30 mg for cortisone acetate, divided into two or three doses, and preferentially
      weight-adjusted. There are indications that the synthetic glucocorticoids have
      undesirable metabolic long-term effects, which make them less suitable as first-line
      treatment.
    explanation: The statement mentions prednisone, but the reference specifically
      discusses hydrocortisone and cortisone acetate, not prednisone.
  - reference: PMID:22695777
    supports: PARTIAL
    snippet: This necessitated an aggressive volume therapy in addition to an initial
      therapy with 100 mg hydrocortisone, 8 g glucose and a continuous administration
      of catecholamines.
    explanation: The reference supports the use of hydrocortisone but does not mention
      prednisone.
  - reference: PMID:23624135
    supports: PARTIAL
    snippet: Patients with Addison&#39;s disease require lifelong treatment with glucocorticoids.
      At present, no glucocorticoid replacement therapy (GRT) can exactly mimic normal
      physiology.
    explanation: The reference supports the need for glucocorticoid replacement therapy
      but does not specify prednisone.
  - reference: PMID:35100642
    supports: PARTIAL
    snippet: Addison&#39;s disease typically results from the autoimmune destruction of
      the adrenal cortex and requires lifelong replacement with glucocorticoids and
      mineralocorticoids.
    explanation: The reference supports the need for glucocorticoid replacement but
      does not specify prednisone.
  - reference: PMID:33993277
    supports: PARTIAL
    snippet: In primary but not in secondary adrenal insufficiency, mortality was
      higher with prednisolone.
    explanation: The reference discusses prednisolone (a form of prednisone) but indicates
      higher mortality associated with its use in primary adrenal insufficiency.
  treatment_term:
    preferred_term: hormone modifying therapy
    term:
      id: MAXO:0000283
      label: hormone modifying therapy
- name: Mineralocorticoid Replacement
  description: Fludrocortisone to replace aldosterone and manage electrolyte balance.
  evidence:
  - reference: PMID:476980
    supports: SUPPORT
    snippet: In four others, PRA remained normal throughout the study, even after
      fludrocortisone had been discontinued, suggesting that the drug was unnecessary
      for the maintenance of normal sodium balance in these patients.
    explanation: The study indicates that fludrocortisone is used in the management
      of Addison&#39;s disease, although not all patients may require it for maintaining
      normal sodium balance.
  - reference: PMID:24755997
    supports: SUPPORT
    snippet: Conventional steroid replacement for Addison&#39;s disease consists of twice
      or three-times daily oral hydrocortisone and once-daily fludrocortisone.
    explanation: This confirms the use of fludrocortisone as part of the conventional
      therapy for Addison&#39;s disease.
  - reference: PMID:25247653
    supports: SUPPORT
    snippet: Many of these patients suffer from adrenal insufficiency and have to
      take either glucocorticoids or a combination of glucocorticoid and mineralocorticoid
      replacement therapy from birth to avoid life-threatening complications.
    explanation: This reference supports the use of mineralocorticoid replacement
      therapy, which includes fludrocortisone, for managing adrenal insufficiency.
  treatment_term:
    preferred_term: hormone modifying therapy
    term:
      id: MAXO:0000283
      label: hormone modifying therapy
- name: Salt Supplementation
  description: Increased salt intake to manage hyponatremia.
  evidence:
  - reference: PMID:28132947
    supports: SUPPORT
    snippet: Treatment involves normalisation of sodium concentration and corticosteroids
      replacement.
    explanation: The literature mentions the normalization of sodium concentration
      as part of the treatment for Addison&#39;s disease, which supports the statement
      about increased salt intake.
  - reference: PMID:20964584
    supports: SUPPORT
    snippet: Primary adrenal insufficiency (i.e. Addison&#39;s disease) may well be recognized
      by clear hall-marks of the disease, such as pigmentation, salt craving, hypotension,
      and concomitant hyperkalemia.
    explanation: The literature indicates salt craving as a hallmark of Addison&#39;s
      disease, supporting the need for increased salt intake.
  - reference: PMID:18471672
    supports: PARTIAL
    snippet: Mineral corticoids may be useful in complicated cases.
    explanation: While this reference mentions mineral corticoids, which are related
      to sodium balance, it does not explicitly support or refute increased salt intake.
  treatment_term:
    preferred_term: nutritional supplementation
    term:
      id: MAXO:0000106
      label: nutritional supplementation
- name: Emergency Medical ID
  description: Patients should carry an ID indicating their condition for emergency
    situations.
  evidence:
  - reference: PMID:19776201
    supports: SUPPORT
    snippet: The endocrinologist has a responsibility to ensure that Addison&#39;s patients
      have adequate access to life-saving emergency injection materials and repeated,
      practical training sessions in how to use them, while the general practitioner
      plays a vital role as in arranging prompt emergency admissions.
    explanation: The literature emphasizes the importance of emergency preparedness
      for Addison&#39;s patients, which implicitly supports the need for carrying an ID
      indicating their condition.
  - reference: PMID:31321757
    supports: SUPPORT
    snippet: Progress in optimizing replacement therapy for patients with AD has allowed
      the patients to lead a normal life. However, continuous education of patients
      and health care professionals of ever-present danger of adrenal crisis is essential
      to save lives of patients with AD.
    explanation: The mention of continuous education and the ever-present danger of
      adrenal crisis supports the need for patients to carry an ID for emergency situations.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
- name: Stress Dose Adjustments
  description: Increased dose of corticosteroids during illness or stress.
  evidence:
  - reference: PMID:18393745
    supports: SUPPORT
    snippet: Patients with adrenal insufficiency (AI) require additional glucocorticoid
      doses during surgery or medical illness, but there is no universally accepted
      regimen for glucocorticoid supplementation therapy.
    explanation: The literature supports the need for increased doses of corticosteroids
      during illness or stress for patients with Addison&#39;s Disease.
  - reference: PMID:29544234
    supports: SUPPORT
    snippet: An adrenal crisis (Addisonian crisis) is an acute life-threatening complication
      of adrenal insufficiency. It occurs when hydrocortisone demand is not met by
      supplementation in the context of an infection - often gastrointestinal, fever,
      trauma, acute psychological or physical stress.
    explanation: The literature supports the need for increased doses of corticosteroids
      during stress to prevent adrenal crisis.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
notes: Prompt diagnosis and lifelong management with hormone replacement therapy are
  essential for preventing adrenal crises and maintaining health.
disease_term:
  preferred_term: Addison disease
  term:
    id: MONDO:0015128
    label: primary adrenal insufficiency
classifications:
  harrisons_chapter:
    - classification_value: endocrine system disorder
    - classification_value: adrenal disorder
    - classification_value: autoimmune disease
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Addisons_Disease.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>